(19)
(11) EP 2 361 913 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 A1)

(48) Corrigendum issued on:
18.04.2012 Bulletin 2012/16

(43) Date of publication:
31.08.2011 Bulletin 2011/35

(21) Application number: 10185841.3

(22) Date of filing: 31.10.2003
(27) Previously filed application:
 31.10.2003 PCT/US03/34707
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
C07D 519/00(2006.01)
C07D 417/04(2006.01)
C07D 417/14(2006.01)
A61P 31/00(2006.01)
C07D 401/04(2006.01)
 C07D 513/04(2006.01)
C07D 495/04(2006.01)
C07D 513/14(2006.01)
A61K 31/554(2006.01)
C07D 215/22(2006.01)
C07D 213/69(2006.01)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 01.11.2002 US 285714
10.04.2003 US 410853
23.07.2003 US 625121
06.10.2003 US 679881

(62) Application number of the earlier application in accordance with Art. 76 EPC:
03768559.1 / 1560827

(71) Applicant: Abbott Laboratories
Abbott Park, Illinois 60064-6008 (US)

(72) Inventors:
  • Pratt, John, K.
    Kenosha, WI 53142 (US)
  • Betebenner, David, A.
    Libertyville, IL 60048 (US)
  • Donner, Pamela, L.
    Mundelein, IL 60060 (US)
  • Green, Brian, E.
    Wonder Lake, IL 60097 (US)
  • Kempf, Dale, J.
    Libertyville, IL 60048 (US)
  • Mcdaniel, Keith, F.
    Wauconda, IL 60084 (US)
  • Maring, Clarence, J.
    Palatine, IL 60067 (US)
  • Stoll, Vincent, S.
    Libertyville, IL 60048 (US)
  • Zhang, Rong
    Niskayuna, NY 12309 (US)

(74) Representative: Modiano, Micaela Nadia et al
Modiano & Partners Thierschstrasse 11
80538 München
80538 München (DE)

 
Remarks:
This application was filed on 01-10-2010 as a divisional application to the application mentioned under INID code 62.
 


(54) Anti-infective agents


(57) The present invention provides an HCV polymerase inhibiting compound having the formula (I) and a composition comprising a therapeutically effective amount of said compound. The present invention also provides a method for inhibiting hepatitis C virus (HCV) polymerase, a method for inhibiting HCV viral replication, and a method for treating or preventing HCV infection. Processes for making said compounds, and synthetic intermediates employed in said processes, are also provided. formula (I)